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Abstract 
Purpose: To investigate the anti-inflammatory activity of Symplocos sumuntia Buch.-Ham. ex D. Don 
and identify the main secondary metabolites responsible for this effect.  
Methods: The in vitro anti-inflammatory activity of the plant extract and isolated compounds was 
determined in terms of the ability to inhibit the production of nitric oxide (NO), and expressions of iNOS 
and COX-2 proteins in RAW264.7 cells stimulated by lipopolysaccharide (LPS). Compounds were 
isolated and identified by spectroscopic methods. 
Results: The methanol extract of S. sumuntia leaves showed strong inhibitory effects on nitric oxide 
(NO) production and expression of iNOS and COX-2 in LPS-induced RAW264.7 cells. A phytochemical 
assay-guided fractionation of the methanol extract of S. sumuntia leaves led to the isolation of four 
lignans which are arctigenin (1), matairesinol (2), monomethylpinoresinol (3) and pinoresinol (4). These 
compounds were identified for the first time from S. sumuntia. All four compounds inhibited the 
production of nitric oxide (NO), with arctigenin showing the most potent activity with half-maximal 
inhibitory concentration (IC50) value of 4.08 µM. 
Conclusion: S. sumuntia is a promising source of anti-inflammatory agents, which may clarify to the 
therapeutic use of this plant in Vietamese traditional medicine. 
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Symplocos is a genus of flowering plants with 
about 300 species distributed in Asia, Australia 
and America [1]. The genus Symplocos is well 
known for their traditional uses in the treatment 
of various diseases such as leprosy, 
gynecological disorders, ulcers, leucorrhea, 
menorrhagia, malaria, and tumefaction. Previous 
investigations indicated that those plants contain 
terpenoids, flavonoids, lignans, phenols, steroids, 
alkaloids, and iridoids [2]. These plants exhibited 
antipyretic, anti-inflammatory, antibacterial, 
antioxidant, and anticancer activities [2,3]. 
Symplocos sumuntia Buch.-Ham. ex D. Don 
(synonym Symplocos caudata Wall. ex G. Don, 
Symplocos tonkinensis Brand) is a Vietnamese 
traditional medicinal herb that grows in the 
mountainous regions at 700-1500 m altitude [4]. 
Roots, leaves and flowers of this plant have been 
used in traditional medicine to treat cough, 
tonsillitis, stomachache, inflammation, 
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hyperlipidemia and hypertension [5]. This plant is 
exploited from natural source for medicinal 
purpose. There are only few reports on the 
chemical composition of S. sumuntia. 
Nortriterpenoid saponins, neolignans, phenolic 
glycosides, daucosterol, glucose, sucrose and 
inositol wereisolated [6,7]. Two other studies 
revealed the presence of neolignan glycosides, 
preneolignan glycoside, phenylpropanoid 
glycosides and cerebroside [8,9]. However, 
literature searches have shown no report on 
biological activities of this plant. 
 
Inflammation is a normal protective process that 
responds to tissue injury. In this process, 
cytokines, such as interleukin (IL)-1β, IL-6, tumor 
necrosis factor (TNF)-α, and inflammatory 
mediator, such as NO and PEG2, are increased 
by activated inflammation cells. It is known that 
inducible nitric oxide synthase (iNOS) and 
cyclooxygenase-2 (COX-2), two major 
inflammatory mediators, are expressed in a 
variety of cells including macrophages in 
response to pro-inflammatory stimuli such as 
lipopolysaccharide (LPS), ILs, and TNF-α [10]. 
They are responsible for the production of NO 
and prostaglandins, which have been implicated 
in the tissue destruction and pathogenesis of a 
number of immunological and inflammatory 
diseases [10]. Overproduction of NO causes 
numerous human diseases, such as arthritis, 
asthma, inflammation, diabetes and cancer [11]. 
Therefore, an assay for inhibition of NO 
production is one of the possible ways to screen 
anti-inflammatory agents [12,13]. 
 
In our continuing search for anti-inflammatory 
agents of natural origin, we found that a 
methanol extract of Symplocos sumuntias trongly 
suppressed the production of NO in LPS-induced 
RAW264.7 cells (with 60.1% at a concentration 
of 30 μg/mL). The present study aims to 
investigate the NO inhibition of this extract and 
identify the main secondary metabolites 







The leaves of Symplocos sumuntia were 
collected at VinhPhuc Province, Vietnam in 
March 2013, and authenticated by Prof Huy Thai 
Tran, Institute of Ecology and Biological 
Resources, VAST. A voucher specimen (no. BK-
B02) was deposited at the herbarium of the 
School of Chemical Engineering, Hanoi 
University of Science and Technology. 
 
Reagents and cell culture 
 
All culture media and reagents were supplied by 
Invitrogen (Grand Island, NY). Primary and 
secondary antibodies were bought from Santa 
Cruz Technology (USA). The macrophage cell 
line, RAW264.7, was purchased from ATCC 
(USA).  
 
Assay for inhibition of NO production 
 
The inhibitory effect of tested samples against 
NO production was evaluated in RAW264.7 cells 
stimulated by lipopolysaccharide (LPS) as 
previously described [14]. The Griess reagent 
was used for quantification of NO levels and cell 
viability was evaluated by 3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) uptake method. 
 
Western blot analysis 
 
RAW264.7 cells were plated in 6 cm dishes at 70 
% confluence and incubated at 37 °C overnight. 
After pre-treatment with tested samples for 30 
min, the cells were incubated with 1 µg/mL LPS 
for another 24 h. The cells were harvested, 
washed twice with ice-cold phosphate-buffered 
saline by centrifugation, and then lysed in lysis 
buffer containing 50 mM Tris-HCl, 50 mM NaCl, 
1 mM EDTA, 5 mM sodium orthovanadate, 1 % 
NP-40 and protease inhibitor cocktail). The cell 
lysates were subjected to electrophoresis on 10 
% sodium dodecyl sulfate-polyacrylamide gel 
and then the proteins were transferred to a 
polyvinylidenedifluoride membrane. The 
membrane was blocked with 5 % skim milk, and 
incubated overnight with primary antibodies of 
iNOS, COX-2 and α-tubulin at 4 °C. The 
corresponding HRP-conjugated secondary 
antibody was then added for 1h incubation at 
room temperature. The signals were detected by 
enhanced chemiluminescent system (Intron, 
Seongnam, Korea) [15]. 
 
Extraction and bioassay-guided isolation 
 
Air-dried and powdered leaves of Symplocos 
sumuntia (4 kg) were extracted three times with 
methanol at 40 oC under ultrasonic condition. 
The combined extracts were concentrated to 
obtain 300 g methanol residue, which was 
suspended in water (2 L), and then successively 
partitioned with n-hexane (1.5 L x 3 times) and 
ethyl acetate (1.5 L x 3 times). The organic 
layers were concentrated to give 36.6 and 66.7 g 
of n-hexane and ethyl acetate residues, 
respectively. The ethyl acetate residue (71 % 
inhibition of NO production at 30 μg/mL) was 
subjected to chromatography on a silica gel 
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column eluted with a mixture of n-hexane and 
acetone (from 100:0 to 0:100 v/v) togive ten 
fractions, F1-F10. Fraction F5 (87 % inhibition of 
NO production at 30 μg/mL) was separated on a 
silica gel column eluting with n-hexane-acetone 
(4:1, v/v) to give four fractions, F5.1-F5.4. 
Fraction F5.1 (98 % inhibition of NO production 
at 30 μg/mL) was further separated by using a 
silica gel column with n-hexane-
dichloromethane-ethyl acetate (2:6:1, v/v/v) as 
eluent, followed by a silica gel column with n-
hexane-dichloromethane-ethyl acetate (8:32:1, 
v/v/v) to obtain compound 1 (885.8 mg) and 
compound 3 (198.3 mg). Fraction F5.3 (92 % 
inhibition of NO production at 30 μg/mL) was 
isolated on a silica gel column elute with n-
hexane-dichloromethane-ethyl acetate (5:40:4, 
v/v/v), followed by a RP-C18 column with 
methanol-water (1:1.2, v/v) as eluent to obtain 
compound 2 (374.3 mg) and compound 4 (7.6 
mg).  
 
Statistical analysis  
 
Each assay was repeated at least three times. 
Means were checked for statistical differences by 





In a screening test for the inhibition of NO 
production in LPS-stimulated RAW 264.7 cells, 
the methanol extract of S. sumuntia leaves (SS) 
showed remarkable inhibitory effect in a dose-
dependent manner. SS did not inhibited NO 
production at low concentration (3 μg/mL). When 
cells were treated with higher concentrations of 
SS (10, 30 and 100 μg/mL), the inhibition 
increased to 23, 44 and 73%, respectively 
(Figure 1). Since COX-2 and iNOS are two major 
inflammatory mediators, and the induced 
expression of iNOS is primarilyresponsible for 
the NO production, we examined SS for 
subsequent study  on the expression of COX-2 
and iNOS. Consistently, in Western blot analysis, 
SS also prevented the LPS-induced expressions 
of COX-2 and iNOS at 10 and 30 µg/mL (Figure 
2). These results suggested that S. sumuntia 
might contain strong anti-inflammatory 
compounds. 
  
Figure 1: Effect of S. sumuntia extract (μg/mL) on the 
NO production in RAW264.7 cells. Cells were 
pretreated with tested samples for 30 min, then 
incubated with 1 μg/mL LPS for 24 h. NO levels were 
quantified by Griess assay. Bars are the standard 
deviations obtained from triplicated experiments; *p < 
0.05 compared to the LPS-treated control 
 
 
Figure 2: Effect of S. sumuntia extract (μg/mL) on iNOS and COX-2 expression. RAW264.7 cells were pretreated 
with tested samples for 30 min, then incubated with 1 μg/mL LPS for indicated times. The levels of iNOS and 
COX-2 proteins were analyzed by Western blot. α-Tubulin was  used as protein loading control. Bars are 
standard deviations obtained from triplicated experiments; *p < 0.05 compared to LPS-treated control 
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Figure 3: Structures of compounds 1-4 isolated from S. sumuntia 
 
Bioassay-guided fractionation of the methanol 
extract of S. sumuntia led to the isolation of four 
lignans (Figure 3). By means of spectroscopic 
methods including mass (MS) and nuclear 
magnetic resonance (NMR) spectroscopy, the 
isolated compounds were identifiedas arctigenin 
(1), matairesinol (2) [16], monomethylpinoresinol 
(3) and pinoresinol (4) [17]. These four 
compounds were isolated for the first time from 
Symplocos sumuntia. 
 
The isolated compounds were tested for their 
inhibition of NO production in LPS-stimulated 
RAW264.7 cells. As shown in Table 1, arctigenin 
(1) was the most active compound with IC50 
value of 4.08 ± 0.26 µM. This effect was 
comparable with the reference control, 
cardamonin. Monomethylpinoresinol (3) exhibited 
moderate inhibitory effect while matairesinol (2) 
and pinoresinol (4) showed weaker inhibition. In 
the MTT assay, these compounds did not affect 
cell viability of RAW264.7 cells at the tested 
concentrations (data not shown). The inhibitory 
effect of compounds 1 and 3 were stronger than 
that of 2 and 4, respectively, suggesting that the 
replacement of a hydroxyl group by a methoxy 
group increased the inhibition of NO production.  
 
Table 1: Inhibitory activity of NO production by 
compounds 1-4 
 
Compound IC50 (μM*) 
Arctigenin (1) 4.08 ± 0.26 
Matairesinol (2) 36.9 ± 1.85 
Monomethyl pinoresinol (3) 13.3 ± 0.94 
Pinoresinol (4) 25.2 ± 1.17 
Cardamonin (control) 2.80 ± 0.18 




It has been reported that the plants of Symplocos 
genus exhibited strong anti-inflammatory activity. 
Jung et al. reported that several flavonoids 
isolated from the aerial parts of S. racemosa 
moderately inhibited NO production with IC50 
values in the range of 42.1 - 88.2 μM [18]. A 
triterpene and a sterol isolated from the stem 
bark of S. paniculata exhibited potent anti-
inflammatory activity in carrageenan induced 
acute paw edema in rats [19]. In a similar study, 
α-spinasterol isolated from S. spicata stem bark 
prevented the development of paw carrageenan 
edema [20]. An ethanol extract of S. racemosa 
barks exhibited anti-inflammatory activity at 100-
500 mg/kg in formalin and carrageenan induced 
mice models [21]. Consistently, our study 
showed that S. sumuntia strongly inhibited NO 
production by decreasing the expression of 
iNOS.  
 
Another major inflammatory mediator, COX-2, 
was also inhibited by S. sumuntia. 
Dibenzylbutyrolactone lignans have been known 
to possess a wide range of biological 
activitiesincluding anti-inflammation [22]. 
Arctigenin, one of the most common 
dibenzylbutyrolactone lignan, is commonly found 
in natural sources such as plants, animals or 
microorganisms. It has been shown to possess 
anti-inflammatory, anticancer, anti-obesity, 
neuroprotection, and free radical scavenging 
properties [23-27]. In the present study, 
arctigenin exhibited potent inhibitory effect 
against NO production. Among four compounds 
isolated from S. sumuntia leaves, this compound 
was found in high content, and therefore might 
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The findings of the present study show that the 
anti-inflammatory activity of S. sumuntia occurs 
via the inhibition of NO production and the 
expression of iNOS and COX-2 proteins. This 
study is the first report on the biological activity of 
Symplocos sumuntia. The results also explained 
the effective use of this plant for treatment of 
inflammation in traditional medicine. Thus, S. 
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